Open Access Articles- Top Results for Interferon alfa 2b

Interferon alfa 2b

Interferon alfa 2b
Clinical data
MedlinePlus a690006
  • US: C (Risk not ruled out)
Subcutaneous, intramuscular
DrugBank DB00105 7pxY
ChEMBL CHEMBL1201558 7pxN
Chemical data
 14pxN (what is this?)  (verify)

Interferon alfa 2b is an antiviral drug originally discovered in the laboratory of Charles Weissmann at the University of Zurich, developed at Biogen, and ultimately marketed by Schering-Plough under the tradename Intron-A. It has been used for a wide range of indications, including viral infections and cancers.

This drug is approved around the world for the treatment of chronic hepatitis C, chronic hepatitis B, hairy cell leukemia, chronic myelogenous leukemia, multiple myeloma, follicular lymphoma, carcinoid tumor, and malignant melanoma.

Interferon alfa-2b products[1]
Product Manufacturer Features Special uses
Alpharona Pharmaclon
Intron-A/IntronA Schering-Plough
Realderon Teva
Reaferon EC GNC Vector
Reaferon EC-Lipint Vector-Medica liposomal
Infagel Vector-Medica ointment
Recolin Vector-Medica
Altevir Bioprocess subsidiary liquid, free of HSA
Viferon Feron suppository or ointment with vitamins C, E viral, bacterial, chlamydiosis
Kipferon Alfarm combination with IgM, IgA, IgG
Giaferon A/S Vitafarma
Genferon Biocad
Grippferon Firn-M nasal formulation influenza
Opthalamoferon Firn-M with dimedrol eye infections
Gerpferon Firn-M with acyclovir, lidocaine ointment herpes

See also


  1. ^ Dmitrij I. Bairamashvili1 and Mikhail L. Rabinovich2* (2007). "Russia through the prism of the world biopharmaceutical market" (PDF). Biotechnol. J 2. 

External links

Lua error in package.lua at line 80: module 'Module:Buffer' not found. Lua error in package.lua at line 80: module 'Module:Buffer' not found.